Nattiya Hirankarn

25PUBLICATIONS
205CO-AUTHORS
ChemotherapySolid tumoursAllergyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 26, 2026
Cannabis Oil and Exploratory Gut-Immune Signatures During Breast Cancer Chemotherapy: A Randomized Pilot Trial.

|May 07, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

|Apr 10, 2026
Allergic reactions in systemic lupus erythematosus: From pathogenic pathways to clinical practice.

Ho Bao Chau Le, Nattiya Hirankarn, Asada Leelahavanichkul

|Jan 16, 2026
A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non-small-cell lung cancer.

Van Hieu Mai, Marisa Prasanpanich, Nicha Zungsontiporn

|Sep 09, 2025
Comparative efficacy and safety of BCMA-targeted CAR T cells and BiTEs in relapsed/refractory multiple myeloma: a meta-analysis of interventional and real-world studies.

Pisanupong Techaapornkun, Waranyoo Rojpalakorn, Nuthchaya Mejun

|May 09, 2025
Novel STAT3 Y360C Gain-of-function Variant Underlies Immune Dysregulation and Aberrancy in Mitochondrial Dynamics.

Kornvalee Meesilpavikkai, Kasiphak Kaikaew, Zijun Zhou

Pageof 5

Frequent Collaborators

4 joint publications

Asada Leelahavanichkul

3 joint publications

Chatphatai Moonla

3 joint publications

Naraporn Somboonna

2 joint publications

Kasama Manothummetha